MRC1 and neoplasm: On the other hand, CD206-expressing monocytic cells are classically associated with an anti-inflammatory phenotype, as described for in vitro differentiated regulatory macrophages (55) or infiltrating CD14+ CD206+ tumor monocytes, which specifically express Arginase-1, IL-10, and TGFβ (56).